Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme

Published:2010-05-24 Issue:6 Volume:12 Page:557-565
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Hawkins Nathaniel M.¹,Wang Duolao²,Petrie Mark C.³,Pfeffer Marc A.⁴,Swedberg Karl⁵,Granger Christopher B.⁶,Yusuf Salim⁷,Solomon Scott D.⁴,Östergren Jan⁸,Michelson Eric L.⁹,Pocock Stuart J.²,Maggioni Aldo P.¹⁰,McMurray John J.V.¹¹,

Affiliation:

1. Liverpool Heart and Chest Hospital; Thomas Drive Liverpool L14 3PE UK

2. Medical Statistics Unit; London School of Hygiene and Tropical Medicine; London UK

3. Golden Jubilee National Hospital; Glasgow UK

4. Brigham and Women's Hospital; Boston MA USA

5. Sahlgrenska University Hospital/Östra; Göteborg Sweden

6. Division of Cardiology; Duke University Medical Center; Durham NC USA

7. Hamilton Health Sciences and McMaster University; Hamilton ON Canada

8. Karolinska Hospital; Stockholm Sweden

9. AstraZeneca LP; Wilmington DE USA

10. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center; Florence Italy

11. University of Glasgow; Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology;Hawkins;Eur J Heart Fail,2009

2. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment;Komajda;Eur Heart J,2003

3. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial;Staszewsky;J Card Fail,2007

4. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease;Cazzola;Drugs,2005

5. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis;Salpeter;Chest,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER;European Journal of Heart Failure;2023-09

2. Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease;Frontiers in Medicine;2022-11-04

3. Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS‐HF and RALES;European Journal of Heart Failure;2021-10-06

4. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review;Cochrane Database of Systematic Reviews;2021-07-26

5. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2021-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3